Motixafortide
Catalog No. A22276
Motixafortide (BKT140 4-fluorobenzoyl) is a novel CXCR4 antagonist with an IC50 vakue of ??1 nM.
| Catalog Num | A22276 |
|---|---|
| M. Wt | 2159.52 |
| Formula | C97H144FN33O19S2 |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 664334-36-5 |
| Synonyms | BKT140 (4-fluorobenzoyl); BL-8040; TF14016 |
| SMILES | [4F-Benzoyl-RR-{2-Naph-Ala}-CY-{Cit}-KKPYR-{Cit}-CR-NH2 (Disulfide bridge: Cys4-Cys13)] |
Motixafortide (BKT140 4-fluorobenzoyl) is a novel CXCR4 antagonist with an IC50 vakue of ??1 nM.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 4.63 mL | 23.15 mL | 46.31 mL |
| 0.5 mM | 0.93 mL | 4.63 mL | 9.26 mL |
| 1 mM | 0.46 mL | 2.32 mL | 4.63 mL |
| 5 mM | 0.09 mL | 0.46 mL | 0.93 mL |
*The above data is based on the productmolecular weight 2159.52. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.